What they found: In normal obese mice: AOD-9604 reduced body fat by 21 % vs placebo, hGH by 24 % The AOD-9604 effect was fully dependent on the 3-adrenergic receptor , in knock-out mice no effect The hGH effect was partly independent of 3-AR , in knock-out mice there was still ~10 % fat reduction AOD-9604 did not raise IGF-1 (control level), whereas hGH raised IGF-1 by 80 % No changes in growth, organ weights (except adipose tissue), fasting insulin Why it matters: The study provided the mechanistic basis for AOD-9604 and confirmed the key business hypothesis: it is possible to separate the lipolytic effect of GH from its growth effect
Anti-Aging & Longevity Studies Research reveals activation of sirtuin 1 pathways through preserved NAD+ levels, triggering longevity-associated genetic programs including enhanced DNA repair, improved mitochondrial function, and reduced inflammatory responses
Compounded tirzepatide vs FDA-approved: a complete visual comparison Understanding the visual differences between compounded and FDA-approved tirzepatide prevents unnecessary confusion
Med Monatsschr Pharm
Molecular Formula: C10H11N2+ Molecular Weight: 159.21 g/mol Potential Applications of 5-Amino-1MQ Laboratory research has indicated that 5-Amino-1MQ peptide may have the following applications: Fat Loss: Support healthy fat metabolism and body composition goals Increases energy expenditure: Helps inhibit NNMT (nicotinamide N-methyltransferase), an enzyme associated with energy regulation and fat storage Supports metabolic efficiency and cellular energy production Prevents muscle loss: Potentially helps maintain lean muscle mass during calorie-controlled diets
